
Novel CK2 ингибитор, targeting an allosteric pocket, exhibiting an IC50 of 3.4 μM against purified CK2α in combination with a favorable selectivity profile
Novel CK2 inhibitor, targeting an allosteric pocket, exhibiting an IC50 of 3.4 μM against purified CK2α in combination with a favorable selectivity profile
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.